In global politics 2025 was the year when an old order ended. President Donald Trump demolished decades-old norms and institutions as dramatically as he set about reshaping the White House. His ...

SINGAPORE, October 22, 2025 (EZ Newswire) -- In a landmark move for the digital trade-finance industry, XDC Ventures, opens new tab, the investment arm of the XDC Network, opens new tab, has announced ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

If you want to learn how to create a Microsoft Account in Windows 11, then this post will help you. A Microsoft account gives you access to all the apps and premium Microsoft services such as Office, ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...

Ras Baraka, the mayor of Newark and a candidate for New Jersey governor, appeared in federal court on Thursday, nearly a week after he was charged with trespassing. By Luis Ferré-Sadurní and Mark ...

Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...

The Omnilux Contour Face Mask is a flexible silicone mask that’s equipped with 132 medical-grade lights, which emit light in two wavelengths—one red and another near-infrared. The brand has a very ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...